Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosanna Tarricone

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 16, 2013
Setting the scene: the challenges of universal health coverage and the contribution of management educationRosanna Tarricone
Health Policy (Amsterdam, Netherlands)|September 6, 2005
Cost-of-illness analysis. What room in health economics?Rosanna Tarricone
BMJ Open|January 19, 2017
Healthcare resource consumption for intermittent urinary catheterisation: cost-effectiveness of hydrophilic catheters and budget impact analysesCarla Rognoni, Rosanna Tarricone
Current Medical Research and Opinion|August 25, 2004
Oxaprozin versus diclofenac in NSAID-refractory periarthritis pain of the shoulderBarbara Heller, Rosanna Tarricone
BMC Urology|January 12, 2017
Intermittent catheterisation with hydrophilic and non-hydrophilic urinary catheters: systematic literature review and meta-analysesCarla Rognoni, Rosanna Tarricone
Clinical Drug Investigation|May 30, 2007
Economic Evaluation of a New Antiemetic Drug - Palonosetron versus Ondansetron : Assessment of the Drug Price Ratio in Five European CountriesRosanna Tarricone, Federica Girolami
Lancet (London, England)|October 25, 2021
The evolution of the Italian National Health ServiceWalter Ricciardi, Rosanna Tarricone
Pharmacoeconomics - Open|February 19, 2022
Feasibility of Deriving Health State Utilities in Mycosis Fungoides Cutaneous T-Cell Lymphoma Using Mapping AlgorithmsMichela Meregaglia, Rosanna Tarricone
Expert Opinion on Pharmacotherapy|March 5, 2003
Economic evaluation of osteoarthritis treatment in EuropeJennifer A Gillette, Rosanna Tarricone
Clinical Drug Investigation|March 12, 2013
An economic perspective on urinary tract infection: the "costs of resignation"Oriana Ciani, Daniele Grassi, Rosanna Tarricone
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 16, 2013
Setting the scene: the challenges of universal health coverage and the contribution of management educationRosanna Tarricone
Health Policy (Amsterdam, Netherlands)|September 6, 2005
Cost-of-illness analysis. What room in health economics?Rosanna Tarricone
BMJ Open|January 19, 2017
Healthcare resource consumption for intermittent urinary catheterisation: cost-effectiveness of hydrophilic catheters and budget impact analysesCarla Rognoni, Rosanna Tarricone
Current Medical Research and Opinion|August 25, 2004
Oxaprozin versus diclofenac in NSAID-refractory periarthritis pain of the shoulderBarbara Heller, Rosanna Tarricone
BMC Urology|January 12, 2017
Intermittent catheterisation with hydrophilic and non-hydrophilic urinary catheters: systematic literature review and meta-analysesCarla Rognoni, Rosanna Tarricone
Clinical Drug Investigation|May 30, 2007
Economic Evaluation of a New Antiemetic Drug - Palonosetron versus Ondansetron : Assessment of the Drug Price Ratio in Five European CountriesRosanna Tarricone, Federica Girolami
Lancet (London, England)|October 25, 2021
The evolution of the Italian National Health ServiceWalter Ricciardi, Rosanna Tarricone
Pharmacoeconomics - Open|February 19, 2022
Feasibility of Deriving Health State Utilities in Mycosis Fungoides Cutaneous T-Cell Lymphoma Using Mapping AlgorithmsMichela Meregaglia, Rosanna Tarricone
Expert Opinion on Pharmacotherapy|March 5, 2003
Economic evaluation of osteoarthritis treatment in EuropeJennifer A Gillette, Rosanna Tarricone
Clinical Drug Investigation|March 12, 2013
An economic perspective on urinary tract infection: the "costs of resignation"Oriana Ciani, Daniele Grassi, Rosanna Tarricone
Pageof 12